FrancophonIA/ELRC3.0 huggingface dataset:
English: Vardenafil dose adjustment might be necessary if moderate CYP3A4 inhibitors such as erythromycin and clarithromycin, are given concomitantly (see sections 4.5 and 4.2).
Maltese: Jista' jkun hemm bżonn tibdil fid-doża ta' vardenafil meta jingħata flimkien ma' inibituri moderati ta' CYP3A4 bħal ma huma erythromycin u clarithromycin (ara sezzjoni 4.2 u 4.5).
English: (cannot be estimated from the available data)
Maltese: (ara s-sezzjoni Mediċini oħra u Vivanza).
English: EU/1/03/249/016 4 tablets
Maltese: EU/1/03/249/005-008, 014
English: No effect on blood pressure was observed when nitroglycerin was taken 24 hours after administration of a single dose of vardenafil 20 mg film-coated tablets.
Maltese: Ma kien osservat l-ebda effett fuq il-pressjoni tad-demm meta nitroglicerine ittieħed 24 siegħa wara l-għoti ta' doza waħda ta' 20 mg vardenafil pilloli miksija b'rita.
English: Vivanza 10 mg orodispersible tablets contain Aspartame and Sorbitol.
Maltese: Vivanza 10 mg pilloli li jinħallu fil-ħalq fihom Aspartame u Sorbitol.
English: The clinical impact of these QT changes is unknown (see section 5.1).
Maltese: impatt kliniku ta' dan it-tibdil fil-QT mhux magħruf (ara sezzjoni 5.1).
English: Effects of other medicinal products on vardenafil
Maltese: Effetti ta' mediċini oħra fuq vardenafil
English: There was no consistent difference in mean Cmax between orodispersible tablets and film-coated tablets.
Maltese: Ma kien hemm l-ebda differenza konsistenti f'Cmax medja bejn pilloli li jinħallu fil-ħalq u pilloli miksija b'rita.
English: Tел.
Maltese: (NAION).
English: Vivanza 10 mg orodispersible tablets
Maltese: Vivanza 10 mg pilloli miksija b'rita
English: Vivanza 10 mg film-coated tablets vardenafil
Maltese: Vivanza 10 mg, pilloli li jinħallu fil-ħalq vardenafil
English: Dyspepsia Gastro-oesophag eal reflux disease Gastritis
Maltese: Aktar tagħrif dwar provi kliniċi
English: They are provided in packs of 4 x 1 orodispersible tablets in alu/alu perforated unit dose blisters.
Maltese: 6.4 Prekawzjonijiet speċjali għall-ħażna Aħżen fil-pakkett oriġinali sabiex tilqa' mid-dawl u mill-umdità.
English: The following groups were not well represented in clinical trials: elderly (>75 years, 2.4%), and patients with certain cardiovascular conditions (see section 4.3).
Maltese: Il-gruppi ta' pazjenti li ġejjin ma kienux rappreżentati tajjeb fil-provi kliniċi: anzjani (>75 sena, 2. 4%), u pazjenti b'ċerti tipi ta' mard kardjovaskulari (ara sezzjoni 4.3).
English: Further information on clinical trials with vardenafil 10 mg orodispersible tablets Efficacy and safety of vardenafil 10 mg orodispersible tablets were separately demonstrated in a broad population in two studies including 701 randomized erectile dysfunction patients who were treated up to 12 weeks.
Maltese: Aktar tagħrif dwar provi kliniċi b'vardenafil 10 mg pilloli li jinħallu fil-ħalq L-effikaċja u s-sigurtà ta' vardenafil 10 mg pilloli li jinħallu fil-ħalq intwerew b'mod separat f'popolazzjoni wiesa' f'żewġ studji li kienu jinkludu 701 pazjent randomised b'disfunzjoni erettili li kienu kkurati sa 12-il ġimgħa.
English: The mean steady state volume of distribution for vardenafil is 208 l, indicating distribution into the tissues.
Maltese: Il-volum ta' distribuzzjoni medju fi stat stabbli huwa ta' 208 lt.
English: Priapism Penile Haemorrhage Haematospermi a
Maltese: L-erezzjoni tal-pene hija proċess emodinamiku.
English: Package Leaflet: Information for the user Vivanza 20 mg film-coated tablets
Maltese: Informazzjoni għall-utent Vivanza 20 mg pilloli miksija b'rita
English: may affect up to 1 in 1,000 users - Inflammation of the eyes (conjunctivitis) - Allergic reaction - Anxiety - Fainting - Amnesia - Seizure - Increased pressure in the eye (glaucoma), lacrimation increased - Effects on the heart (such as heart attack, altered heart beat or angina) - High or low blood pressure - Nose bleed - Effect on results of blood tests to check liver function - Sensitivity of the skin to sun light - Painful erections - Chest pain - Temporarily decreased blood flood to parts of the brain
Maltese: - Tnemnim u perċezzjoni mnaqqsa tal-mess - Ħedla ta' ngħas - Effetti fuq il-vista, ħmura fl-għajn, effetti fuq il-ħila biex tagħraf il-kuluri, uġigħ u skomdu fl għajn, sensittività għad-dawl
English: Syncope Seizure Amnesia Transient ischaemic attack
Maltese: IL-PRODOTTI MEDIĊINALI, JEKK HEMM BŻONN
English: • When vardenafil (film-coated tablets) was given at doses of 5 or 10 mg on a background of stable therapy with alfuzosin, compared to placebo, there was no symptomatic reduction in blood pressure.
Maltese: • Meta vardenafil (pilloli miksija b'rita) ingħata f'dożi ta' 5 jew 10 mg lil pazjenti stabbli fuq terapija b'alfuzosin, meta mqabbel mal-plaċebo, ma kien hemm l-ebda tnaqqis sintomatiku fil pressjoni tad-demm.
English: EU/1/03/249/001-004, 013 EU/1/03/249/005-008, 014 EU/1/03/249/009-012, 015
Maltese: TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ EU/1/03/249/001-004, 013
English: 2x (1 vial + 1 syringe + 1 needle + 1 vial adapter + 2 alcohol pads)
Maltese: 2x (1 kunjett + 1 siringa + 1 labra + 1 adapter talkunjett + 2 pads tal-alkoħol)
English: 1 pre-filled syringe + 2 alcohol pads
Maltese: 1 siringa mimlija għal-lest + 2 pads tal-alkoħol
English: Subcutaneous use vial (glass)
Maltese: Soluzzjoni għall-injezzjoni kunjett (ħġieġ)
English: 1 pre-filled pen + 2 alcohol pads
Maltese: 1 pinna mimlija għal-lest + 2 pads tal-alkoħol
English: Route Nationale 306
Maltese: CIS bio international Route Nationale 306
English: Saclay BP 32
Maltese: Saclay B.P. 32
English: (1/10,000 to <1/1,000)
Maltese: (1/10,000 sa <1/1,000)
English: These include: - amfetamine, - benzatropine, - bupropion, - cocaine, - mazindol, - methylphenidate, - phentermine and - sertraline.
Maltese: - amphetamine, - benzatropine, - bupropion, - cocaine, - mazindol, - methylphenidate, - phentermine u - sertraline.
English: Iodine-123 has a physical half-life of 13.2 hours.
Maltese: Iodine-123 għandu half-life fiżika ta' 13.2 sigħat.
English: (1/100 to <1/10)
Maltese: (1/100 sa <1/10)
English: Uncommon (1/1,000 to <1/100) Rare
Maltese: Mhux komuni (1/1,000 sa <1/100) Rari
English: Dizziness, formication (paraesthesia), dysgeusia
Maltese: Sturdament, formikazzjoni (paraesteżija), disgewsja
English: Striascan contains alcohol (ethanol) 5 % by volume.
Maltese: Striascan fih l-alkoħol (ethanol) 5% skont il-volum.
English: Adverse reaction Preferred term
Maltese: Reazzjoni avversa Terminu ppreferut
English: I) at reference time (0.07 to 0.13 µg/mL of ioflupane).
Maltese: I) mill-ħin ta' riferiment (0.07 sa 0.13 µg/mL ta'
English: Excipient with known effect This medicinal product contains 39.5 g/L ethanol.
Maltese: Dan il-prodott mediċinali fih 39.5 g/L ta' ethanol.
English: Bq/mmol) at reference time.
Maltese: Bq/mmol) mill-ħin ta' riferiment.
English: I) adopted by ICRP 128 ((International Commission on Radiological Protection ,2015) assumes initial uptake of 31% of the administered activity in the liver, 11% in the lungs, and 4% in the brain.
Maltese: I) adottat mill-ICRP 128 (International Commission on Radiological Protection, Il-Kummissjoni Internazzjonali għall-Protezzjoni Radjuloġika, 2015) jassumi teħid inizjali ta' 31% tal-attività mogħtija fil-fwied, 11% fil-pulmun, u 4% fil-moħħ.
English: Acetic acid, glacial (E 260) Sodium acetate, trihydrate (E 262) Ethanol, anhydrous (E 1510) Phosphoric acid, concentrated (E 338) Water for injections
Maltese: Sodium acetate, trihydrate (E 262) Ethanol, anhydrous (E 1510) Phosphoric acid, concentrated (E 338)
English: Volume: 5 mL
Maltese: Volum: 5 mL
English: In a clinical trial including evaluation of 288 subjects with dementia with Lewy bodies (DLB) (144 subjects), Alzheimer's disease (124 subjects), vascular dementia (9 subjects) or other (11 subjects), the results of an independent, blinded visual assessment of the ioflupane (
Maltese: Studji kliniċi f'pazjenti bid-dimenzja b'korpi Lewy Fi prova klinika li kienet tinkludi l-evalwazzjoni ta' 288 pazjent b'dimenzja b'korpi Lewy (DLB) (144 pazjent), il-marda ta' Alzheimer (124 pazjent), dimenzja vaskulari (9 pazjenti) jew oħrajn (11-il pazjent), ir-riżultati ta' valutazzjoni indipendenti u blinded tal-immaġini ioflupane (
English: Striascan is contraindicated in pregnancy (see section 4.3).
Maltese: Striascan hu kontraindikat waqt it-tqala (ara sezzjoni 4.3).
English: The quantity to be administered usually recommended for an adult ranges from 110 to 185 MBq (megabecquerel or MBq, the unit used to measure radioactivity).
Maltese: Il-kwantità li għandha tingħata u li normalment hija rrakkomandata għal adult tvarja bejn 110 sa 185 MBq (megabecquerel jew MBq, l-unità użata fil-kejl tar-radjuattività).
English: - The other ingredients are acetic acid, glacial (E 260); sodium acetate trihydrate (E 262), ethanol, anhydrous (E 1510); phosphoric acid, concentrated (E 338) and water for injections.
Maltese: - Is-sustanzi mhux attivi l-oħra huma acetic acid, glacial (E 260); sodium acetate trihydrate (E 262), ethanol, anhydrous (E 1510); phosphoric acid, concentrated (E 338) u ilma għallinjezzjonijiet.
English: Radioactive medicine.
Maltese: Mediċina radjuattiva.
English: E 1510 (see leaflet for further information), E 260, E 262, E 338, water for injections.
Maltese: E 1510 (ara l-fuljett għal aktar tagħrif), E 260, E 262, E 338, ilma għall-injezzjonijiet.
English: EU/1/19/1372/001 (2.5 mL) EU/1/19/1372/002 (5 mL)
Maltese: EU/1/19/1372/002 (5 mL)
English: Other medicines and Striascan
Maltese: Mediċini oħra u Striascan
English: The effective dose (E) resulting from administration of 185 MBq of Striascan injection is 4.6 mSv (per 70 kg individual).
Maltese: Id-doża effettiva (E) li tirriżulta meta jingħata Striascan ta' 185 MBq f'injezzjoni hija ta' 4.6 mSv (għal kull individwu ta' 70 kg).
English: Very common (1/10) Common
Maltese: Komuni ħafna (1/10) Komuni
English: I) are listed below according to ICRP 128.
Maltese: I) huma elenkati hawn taħt skont l-ICRP 128.
English: This medicinal product contains 39.5 g/L (5% volume) ethanol (alcohol), up to 197 mg per dose, equivalent to 5 mL beer or 2 mL wine.
Maltese: Dan il-prodott mediċinali fih 39.5 g/L (5% tal-volum) ta' ethanol (alkoħol), li jitla' għal 197 mg għal kull doża, li hu ekwivalenti għal 5 mL ta' birra jew 2 mL ta' nbid.
English: Erythema, pruritus, rash, urticaria, hyperhidrosis
Maltese: Eritema, ħakk, raxx, urtikarja, għaraq eċċessiv
English: For an administered activity of 185 MBq the typical radiation dose to the target organ (brain) is 3 mGy and the typical radiation doses to the critical organs: liver and colon wall are 16 mGy and 11 mGy, respectively.
Maltese: Għal attività mogħtija ta' 185 MBq id-doża ta' radjazzjoni tipika lill-organu fil-mira (il-moħħ) hija ta' 3 mGy u d-dożi ta' radjazzjoni tipiċi lill-organi kritiċi: il-fwied u r-rita tal-kolon hija ta' 16 mGy u 11 mGy, rispettivament.
English: Volume: 2.5 mL
Maltese: 2.5 mL
English: • In adult patients, to help differentiate probable dementia with Lewy bodies from Alzheimer's disease.
Maltese: • F'pazjenti adulti, biex ikun hemm divrenzjar bejn dimenzja probabbli mal-korpi Lewy minħabba l-marda ta' Alzheimer.
English: Pharmacotherapeutic group: Diagnostic radiopharmaceutical central nervous system, ATC code: V09AB03.
Maltese: Dijanjostika radjufarmaċewtika tas-sistema nervuża ċentrali, Kodiċi ATC:
English: Clinical categorisation into the respective dementia group was based on a standardised and comprehensive clinical and neuropsychiatric evaluation.
Maltese: Il-kategorizzazzjoni klinika fil-grupp rispettiv ta' dimenzja kienet ibbażata fuq standardizzazzjoni u evalwazzjoni klinika u newropsikjattrika komprensiva.
English: Striascan is unable to discriminate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Maltese: Striascan ma jistax jagħraf bejn il-marda ta' Parkinson, atrofija multipla tas-sistema u paraliżi progressiva supranukleari.
English: MedDRA Body system SOCs
Maltese: Sistema tal-Ġisem MedDRA
English: • methylphenidate (used to treat hyperactivity in children and narcolepsy (excessive sleepiness))
Maltese: • methylphenidate (jintuża biex jikkura iperattività fit-tfal u narkolepsija (irqad eċċessiv))
English: 80.2% and specificity from 81.3% to 83.9% when the possible DLB patients were included as non-DLB patients.
Maltese: 81.3% sa 83.9% meta l-pazjenti DLB possibbli ġew inklużi bħala pazjenti li mhumiex DLB.
English: As the effective dose is 4.6 mSv when the maximal recommended activity of 185 MBq is administered these adverse events are expected to occur with a low probability.
Maltese: Minħabba li d-doża effettiva hija ta' 4.6 mSv meta tingħata l-attività rakkomandata massimali ta' 185 MBq, dawn l-avvenimenti avversi huma mistennija li jseħħu bi probabbiltà baxxa.
English: Clinical efficacy has been demonstrated across the range 110 to 185 MBq.
Maltese: L-effikaċja klinika ntweriet fil-medda ta' 110 sa 185 MBq.
English: This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially ‘sodium-free'.
Maltese: Dan il-prodott mediċinali fih anqas minn 1 mmol sodium (23 mg) f'kull kunjett, jiġifieri essenzjalment ‘ħieles mis-sodium'.
English: Please refer to section 2 “Striascan contains ethanol.”
Maltese: Jekk jogħġbok irreferi għas-sezzjoni 2 “Striascan fih l-ethanol.
English: Uncommon: may affect up to 1 in 100 people - Increased appetite - Dizziness - Taste disturbance - Nausea - Dry mouth - Vertigo - A brief irritating feeling similar to ants crawling over your skin (formication) - Intense pain (or burning sensation) at the injection site.
Maltese: Mhux komuni: jista' jaffettwa sa persuna 1 minn kull 100 - Żieda fl-aptit - Sturdament - Disturbi fit-togħma - Dardir - Ħalq xott - Mejt - Sensazzjoni irritanti bħal qisu hemm in-nemel miexi fuq il-ġilda tiegħek (formikazzjoni) - Uġigħ qawwi (jew sensazzjoni ta' ħruq) fis-sit tal-injezzjoni.
English: No data are available (see section 4.4).
Maltese: L-ebda data mhi disponibbli (ara sezzjoni 4.4).
English: Manufacturer name address CIS bio international F-91192 GIF-SUR-YVETTE CEDEX
Maltese: Simbolu ta' radjuattività Isem u indirizz tal-Manifattur CIS bio international F-91192 GIF-SUR-YVETTE CEDEX
English: Symbol of radioactivity
Maltese: Simbolu ta' radjuattività
English: Active substances shown during clinical trials not to interfere with Striascan imaging include: - amantadine, - trihexyphenidyl, - budipine, - levodopa, - metoprolol, - primidone, - propranolol and - selegiline.
Maltese: Sustanzi attivi li fil-provi kliniċi wrew li ma jxekklux il-viżjoni permezz ta' Striascan jinkludu: - amantadine, - trihexyphenidyl, - budipine, - levodopa, - metoprolol, - primidone, - propranolol u - selegiline.
English: The camera pictures are usually taken 3 to 6 hours after the injection of this product.
Maltese: Ir-ritratti tal-kamera ġeneralment jittieħdu bejn 3 u 6 sigħat wara l-injezzjoni ta' dan il-prodott.
English: • In adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Maltese: • F'pazjenti adulti li jbatu bis-sindromi ta' Parkinson li għadhom mhux ċerti klinikament, pereżempju dawk b'sintomi bikrin, biex jgħin jagħraf bejn tregħid essenzjali u sindromi ta' Parkinson relatati mal-marda ta' Parkinson idjopatika, atrofija multipla tas-sistema u paraliżi progressiva supranukleari.
English: I) results in an absorbed dose to the uterus of 2.6 mGy.
Maltese: I), din tiġi assorbita fl-utru b'rata ta' 2.6 mGy.
English: Normal images are characterised by two symmetrical crescent-shaped areas of equal intensity.
Maltese: Immaġini normali huma karatterizzati minn żewġ partijiet simetriċi forma ta' felli tal-istess intensità.
English: EXP: DD/MM/YYYY xx h xx CET
Maltese: JIS : JJ/XX/SSSS xx h xx CET
English: Each 5 mL single dose vial contains 370 MBq ioflupane (
Maltese: Kull kunjett b'doża waħda ta' 5 mL fih 370 MBq ta' ioflupane (
English: Striascan contains the active substance ioflupane (
Maltese: Striascan fih is-sustanza attiva ioflupane (
English: Ioflupane also binds to the serotonin transporter on 5-HT neurons but with lower (approximately 10-fold) binding affinity.
Maltese: Ioflupane jintrabat ukoll mat-trasportatur ta' serotonin fuq newroni 5-HT imma b'affinità anqas qawwija tar-rabta (bejn wieħed u ieħor 10 darbiet).
English: Gallbladder wall Gastrointestinal tract Stomach wall
Maltese: Rita tal-borża tal-marrara Passaġġ gastrointestinali
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c (7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Maltese: • Rapporti Perjodiċi Aġġornati dwar is-Sigurtà Ir-rekwiżiti biex jiġu ppreżentati rapporti perjodiċi aġġornati dwar is-sigurtà għal dan il-prodott mediċinali huma mniżżla fil-lista tad-dati ta' referenza tal-Unjoni (lista EURD) prevista skont lArtikolu 107c (7) tad-Direttiva 2001/83/KE u kwalunkwe aġġornament sussegwenti ppubblikat fuq il-portal elettroniku Ewropew tal-mediċini.
English: I) can be used as a surrogate marker to examine the integrity of the dopaminergic nigrostriatal neurons.
Maltese: I) radjutikkettat jista' jintuża bħala markatur alternattiv biex jeżamina l-integrità tan-newroni dopaminerġiċi nigristrijatali.
English: Striascan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:
Maltese: Striascan huwa indikat għall-osservazzjoni tan-nuqqas tat-terminals tan-newroni dopaminerġiċi li jiffunzjonaw fl-istrajatum:
English: Adequate shielding is mandatory.
Maltese: Protezzjoni ta' lqugħ adegwata hija obbligatorja.
English: - Hypersensitivity (allergic) - Shortness of breath - Redness of the skin - Itching - Rash - Hives (urticaria) - Excessive sweating - Vomiting - Low blood pressure - Feeling hot.
Maltese: - Sensittività eċċessiva (allerġika) - Qtugħ ta' nifs - Ħmura tal-ġilda - Ħakk - Raxx - Ħorriqija (urtikarja) - Għaraq eċċessiv - Rimettar - Pressjoni baxxa - Tħoss is-sħana
English: Metal Box / Lead Pot - 2.5 mL presentation
Maltese: Ż-ŻGĦAR EWLENIN Kunjett - preżentazzjoni tat-2.5 mL
English: Children and adolescents Striascan is not recommended for children and adolescents aged 0 to 18 years.
Maltese: Tfal u adolexxenti Striascan mhuwiex rakkommandat għal tfal u adolexxenti li jkollhom minn 0 sa 18-il sena.
English: How Striascan is used
Maltese: Striascan 74
English: Pack size: 1 vial containing 2.5 mL or 5 mL.
Maltese: Daqs tal-pakkett: kunjett wieħed li fih 2.5 mL jew 5 mL.
English: Marketing authorisation holder and manufacturer: CIS bio international
Maltese: CIS bio international
English: This exposure is less than in some types of X-ray investigation.
Maltese: Dan l-esponiment huwa inqas milli f'xi tipi ta' investigazzjonijiet b'X-ray.
English: Experimental studies with a striatal phantom, suggest that optimal images are obtained with matrix size and zoom factors selected to give a pixel size of 3.5-4.5 mm for those systems currently in use.
Maltese: Studji sperimentali b'kontenitur radjuattiv għall-provi tar-ritratti tal-korpus striatum, jissuġġerixxu li l-aħjar immaġini jittieħdu meta d-daqs tal-matrici u lfatturi taż-‘zoom' jagħtu daqs tal-pixel ta' bejn 3.5 u 4.5 mm għas-sistemi li qed jintużaw bħalissa.
English: If in doubt about her potential pregnancy (if the woman has missed a period, if the period is very irregular, etc.), alternative techniques not using ionising radiation (if there are any) should be offered to the patient.
Maltese: Jekk ikun hemm xi dubju dwar il-possibbiltà li tkun tqila (jekk il-mara ma kellhiex l-aħħar mestrwazzjoni, jekk il-mestrwazzjoni huwa irregolari ħafna, eċċ.), għandhom jiġu offruti tekniki alternattivi li ma jinvolvux radjazzjoni jonizzanti (jekk ikunu disponibbli) lill-pazjent.
English: Activity in the liver is excreted according to the Publication 53 gallbladder model (ICRP, 1987), where 30% is eliminated via the gallbladder and the remainder passes directly into the small intestine.
Maltese: L-attività fil-fwied titneħħa skont il-mudell tal-borża tal-marrara tal-Pubblikazzjoni 53 (ICRP, 1987), fejn 30% tiġi eliminata permezz tal-marrara u lkumplament jgħaddi direttament fil-musrana ż-żgħira.
English: Metal Box / Lead Pot - 5 mL presentation
Maltese: Ż-ŻGĦAR EWLENIN Kunjett - preżentazzjoni tal-5 mL
English: The biokinetic model for ioflupane (
Maltese: DOŻIMETRIJA Il-mudell bijokinetiku għal ioflupane (
English: 370 MBq / vial DD/MM/YYYY xx h xx CET 74 MBq / mL DD/MM/YYYY xx h xx CET
Maltese: MBq / mL JJ/XX/SSSS xx h xx CET
English: Precautions with respect to environmental hazard see section 6.6.
Maltese: Għall-prekawzjonijiet fir-rigward tal-periklu ambjentali ara sezzjoni 6.6.
English: Uptake in the brain is rapid, reaching about 7% of injected activity at 10 minutes post-injection and decreasing to 3% after 5 hours.
Maltese: Il-prodott malajr imur fil-moħħ, u jilħaq 7% tal-attività injettata 10 minuti wara l-injezzjoni u jonqos għal 3% wara 5 sigħat.
English: • amfetamine (used to treat hyperactivity in children and narcolepsy (excessive sleepiness);
Maltese: • amfetamine (jintuża biex jikkura iperattività fit-tfal u narkolepsija (irqad eċċessiv); jista'
English: 370 MBq / vial at ref. (see outer label) 74 MBq / mL
Maltese: 370 MBq/ kunjett fir-ref.
English: Vial - 2.5 mL presentation
Maltese: Kunjett ta' 2.5 mL
English: Images should be acquired using a gamma camera fitted with a high-resolution collimator and calibrated using the 159 keV photopeak and a ± 10% energy window.
Maltese: L-immaġini jittieħdu b'kamera gamma li jkollha kollimatur ta' reżoluzzjoni għolja u tkun ikkalibrata bl-użu tal-159 keV bħala l-ogħla livell ta' dawl u tieqa ta' enerġija ta' ± 10%.
English: This is normal practice with medicines like Striascan.
Maltese: Din hija prattika normali b'mediċini bħal Striascan.
English: The values for the sensitivity of ioflupane (
Maltese: Il-valuri għas-sensittività ta' ioflupane (
English: For all organs and tissues, 80% is assumed to be excreted with a biological half-time of 58 h, and 20% with a half-time of 1.6 h. It is further assumed that 60% of the injected activity is excreted to the urine, and 40% is excreted to the gastrointestinal tract for all organs and tissues.
Maltese: Huwa preżunt ukoll li 60% tal-attività injettata titneħħa mal-awrina, u 40% titneħħa mill-apparat gastrointestinali għall-organi u t-tessuti kollha.
English: At 48 hours post-injection, approximately 60% of the injected radioactivity is excreted in the urine, with faecal excretion calculated at approximately 14%.
Maltese: 48 siegħa wara l-injezzjoni, bejn wieħed u ieħor 60% tar-radjuattività li tiġi injettata titneħħa flawrina, u hu kkalkulat li 14% jitneħħa fl-ippurgar.
English: • benzatropine (used to treat Parkinson's disease)
Maltese: • benzatropine (jintuża biex jikkura l-marda ta' Parkinson)
English: I) in determining probable DLB from non-DLB ranged from 75.0% to 80.2% and specificity from 88.6% to 91.4%.
Maltese: I) li jistabbilixxu l-probabbiltà ta' DLB minn dak li mhux DLB kienu fil-firxa ta' bejn 75.0% sa 80.
English: 185 MBq / vial at ref. (see outer label) 74 MBq / mL
Maltese: Volum : 2.5 mL 185 MBq/ kunjett fir-ref.
English: 185 MBq / vial DD/MM/YYYY xx h xx CET 74 MBq / mL DD/MM/YYYY xx h xx CET
Maltese: MBq / kunjett JJ/XX/SSSS xx h xx CET 74
English: The vial is placed into a lead container for protective shielding and packed in a metal box.
Maltese: Il-kunjett jitqiegħed f'kontenitur taċ-ċomb għal ilqugħ protettiv u jiġi ppakkjat f'kaxxa tal-metall.
English: The values are calculated assuming urinary bladder emptying at 4.8-hour intervals and appropriate thyroid blocking (Iodine-123 is a known Auger electron emitter)
Maltese: Il-valuri huma kkalkulati billi nassumu li l-borża ta' l-urina qed titbattal f'intervalli ta' 4.8 sigħat u limblukkar tat-tirojde qed isir b'mod xieraq (Il-Jodju-123 huwa magħruf li jemetti elettroni Auger).
English: EXP: 20 h post-ref.
Maltese: JIS: 20 siegħa wara l-ħin ta' riferiment.
English: Vial - 5 mL presentation
Maltese: Kunjett ta' 5 mL